Current and future treatment of amyloid diseases.

@article{Ankarcrona2016CurrentAF,
  title={Current and future treatment of amyloid diseases.},
  author={Maria Ankarcrona and Bengt Winblad and Cecilia Monteiro and Colleen Fearns and Evan T Powers and Jan J Johansson and Gunilla Torstensdotter Westermark and Jenny Presto and B G Ericzon and Jeffery W Kelly},
  journal={Journal of internal medicine},
  year={2016},
  volume={280 2},
  pages={177-202}
}
There are more than 30 human proteins whose aggregation appears to cause degenerative maladies referred to as amyloid diseases or amyloidoses. These disorders are named after the characteristic cross-β-sheet amyloid fibrils that accumulate systemically or are localized to specific organs. In most cases, current treatment is limited to symptomatic approaches and thus disease-modifying therapies are needed. Alzheimer's disease is a neurodegenerative disorder with extracellular amyloid β-peptide… CONTINUE READING
Highly Cited
This paper has 27 citations. REVIEW CITATIONS
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 174 references

Opportunities and Challenges of Tunnel FETs

IEEE Transactions on Circuits and Systems I: Regular Papers • 2016

Brain Microbleeds 12 Years after Orthotopic Liver Transplantation in Val30Met Amyloidosis.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association • 2015

Combined heart-liver transplantation: a single-center experience.

Transplant international : official journal of the European Society for Organ Transplantation • 2015

Similar Papers

Loading similar papers…